| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2011.03.081 |
| P8608 | Fatcat ID | release_cpw4uz64efa55kc3ndgtn7gqzi |
| P698 | PubMed publication ID | 21481328 |
| P50 | author | Beatrix Grubeck-Loebenstein | Q21255470 |
| P2093 | author name string | Michael Keller | |
| Stefan Seidel | |||
| Sanja Selak | |||
| Eszter Nagy | |||
| Christoph Reinisch | |||
| Karen Lingnau | |||
| Petra Schlick | |||
| Petra Schmid | |||
| Zoltan Magyarics | |||
| Barbara Luhan | |||
| P2860 | cites work | Vaccines in the era of genomics: the pneumococcal challenge | Q28290283 |
| Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells | Q29618163 | ||
| Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins | Q33202131 | ||
| Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies | Q33312893 | ||
| Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia | Q33360868 | ||
| Interleukin-17A mediates acquired immunity to pneumococcal colonization | Q33370537 | ||
| Regulation of production of mucosal antibody to pneumococcal protein antigens by T-cell-derived gamma interferon and interleukin-10 in children. | Q41827353 | ||
| Challenges for vaccination in the elderly. | Q41957098 | ||
| The immune response to pneumococcal proteins during experimental human carriage | Q42944608 | ||
| The pneumococcal eukaryotic-type serine/threonine protein kinase StkP co-localizes with the cell division apparatus and interacts with FtsZ in vitro | Q43132784 | ||
| T cell memory response to pneumococcal protein antigens in an area of high pneumococcal carriage and disease | Q43645903 | ||
| Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media | Q44836024 | ||
| Defective cell wall synthesis in Streptococcus pneumoniae R6 depleted for the essential PcsB putative murein hydrolase or the VicR (YycF) response regulator | Q45014787 | ||
| Characterization of a eukaryotic type serine/threonine protein kinase and protein phosphatase of Streptococcus pneumoniae and identification of kinase substrates. | Q45273413 | ||
| Regulation of IL-17 in human CCR6+ effector memory T cells. | Q51964294 | ||
| Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children. | Q51977040 | ||
| Altered memory B-cell homeostasis in human aging. | Q52011425 | ||
| The Immunogenicity of 7‐Valent Pneumococcal Conjugate Vaccine versus 23‐Valent Polysaccharide Vaccine in Adults Aged 50–80 Years | Q57385750 | ||
| Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults | Q71007455 | ||
| Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection | Q72022248 | ||
| Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA | Q73166608 | ||
| Functional analysis of a PcsB-deficient mutant of group B streptococcus | Q73269246 | ||
| Human antibodies to pneumococcal surface protein A in health and disease | Q73491325 | ||
| Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children | Q73585328 | ||
| A eukaryotic-type serine/threonine protein kinase StkP of Streptococcus pneumoniae acts as a dimer in vivo | Q79791550 | ||
| Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers | Q80006417 | ||
| Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults | Q80128843 | ||
| Serum antibodies to the pneumococcal surface proteins PhtB and PhtE in Finnish infants and adults | Q80237417 | ||
| Insufficient protection for healthy elderly adults by tetanus and TBE vaccines | Q81661572 | ||
| Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly | Q82518964 | ||
| T cell responses are better correlates of vaccine protection in the elderly | Q83276474 | ||
| Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older | Q33542866 | ||
| Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage | Q33798317 | ||
| Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty | Q33896033 | ||
| Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group | Q33896897 | ||
| Efficacy of a pneumococcal conjugate vaccine against acute otitis media | Q33932973 | ||
| CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization | Q33935327 | ||
| Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial | Q33986009 | ||
| Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination. | Q34001923 | ||
| Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae | Q34003306 | ||
| Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis | Q34005995 | ||
| Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells. | Q34768051 | ||
| Dynamics of nasopharyngeal colonization by potential respiratory pathogens | Q35056169 | ||
| Streptococcus pneumoniae colonisation: the key to pneumococcal disease | Q35681330 | ||
| Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. | Q35689099 | ||
| Eukaryotic-type serine/threonine protein kinase StkP is a global regulator of gene expression in Streptococcus pneumoniae | Q35879288 | ||
| Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. | Q36089312 | ||
| Humoral immune response and B-cell functions including immunoglobulin class switch are downregulated in aged mice and humans | Q36183460 | ||
| B cell development and receptor diversity during aging | Q36213043 | ||
| Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins | Q36313904 | ||
| Inflammation markers predicting frailty and mortality in the elderly. | Q36388062 | ||
| Antibody quality in old age. | Q36445511 | ||
| Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies | Q36558990 | ||
| Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans | Q36658296 | ||
| B-cell diversity decreases in old age and is correlated with poor health status | Q37155196 | ||
| Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice | Q37190966 | ||
| Influences of capsule on cell shape and chain formation of wild-type and pcsB mutants of serotype 2 Streptococcus pneumoniae. | Q37191467 | ||
| The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. | Q37280352 | ||
| Pneumococcal vaccination of elderly adults: new paradigms for protection. | Q37290048 | ||
| Immunosenescence and vaccine failure in the elderly | Q37538366 | ||
| Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development | Q37668036 | ||
| Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children | Q39656521 | ||
| The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease. | Q39910189 | ||
| Human antibody response towards the pneumococcal surface proteins PspA and PspC during invasive pneumococcal infection | Q40285793 | ||
| The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis | Q40332317 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3982-3989 | |
| P577 | publication date | 2011-04-08 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age. | |
| P478 | volume | 29 |
| Q64119526 | A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Challenge |
| Q35668540 | A Serine-Threonine Kinase (StkP) Regulates Expression of the Pneumococcal Pilus and Modulates Bacterial Adherence to Human Epithelial and Endothelial Cells In Vitro |
| Q36013814 | Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country |
| Q36731284 | Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses |
| Q36999810 | Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults |
| Q47658958 | Development of pneumococcal vaccines over the last 10 years |
| Q38140041 | Exploitation of physiology and metabolomics to identify pneumococcal vaccine candidates |
| Q39037134 | Genetic conjugation of components in two pneumococcal fusion protein vaccines enhances paediatric mucosal immune responses |
| Q90602359 | Immunologic Dysfunction Contributes to the Otitis Prone Condition |
| Q90136333 | Immunosenescence and human vaccine immune responses |
| Q38185814 | Immunosenescence and pneumococcal disease: an imbalance in host-pathogen interactions |
| Q24625664 | Interleukin-17 production and T helper 17 cells in peripheral blood mononuclear cells in response to ocular lysate in patients with birdshot chorioretinopathy |
| Q58596157 | Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation |
| Q35665351 | Novel protein-based pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce protective immunity against pneumococcal disease in neonatal mice |
| Q37309218 | Rationale and prospects for novel pneumococcal vaccines |
| Q27009118 | Recent advances in pneumococcal peptidoglycan biosynthesis suggest new vaccine and antimicrobial targets |
| Q38069943 | Serotype-independent pneumococcal vaccines. |
| Q39146450 | The contrasting roles of Th17 immunity in human health and disease |
| Q92968776 | Vaccination for the control of childhood bacterial pneumonia - Haemophilus influenzae type b and pneumococcal vaccines |
Search more.